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ABSTRACT
The description of the interactome represents
one of key challenges remaining for structural
biology. Physiologically important weak interac-
tions, with dissociation constants above 100kM,
are remarkably common, but remain beyond the
reach of most of structural biology. NMR spectro-
scopy, and in particular, residual dipolar couplings
(RDCs) provide crucial conformational constraints
on intermolecular orientation in molecular com-
plexes, but the combination of free and bound
contributions to the measured RDC seriously com-
plicates their exploitation for weakly interacting
partners. We develop a robust approach for
the determination of weak complexes based on:
(i) differential isotopic labeling of the partner pro-
teins facilitating RDC measurement in both part-
ners; (ii) measurement of RDC changes upon
titration into different equilibrium mixtures of par-
tially aligned free and complex forms of the pro-
teins; (iii) novel analytical approaches to determine
the effective alignment in all equilibrium mixtures;
and (iv) extraction of precise RDCs for bound
forms of both partner proteins. The approach is
demonstrated for the determination of the three-
dimensional structure of the weakly interacting
CD2AP SH3-C:Ubiquitin complex (Kd=132 13kM)
and is shown, using cross-validation, to be highly
precise. We expect this methodology to extend the
remarkable and unique ability of NMR to study
weak protein–protein complexes.
INTRODUCTION
Following the successful development of structural geno-
mic initiatives dedicated to the determination of the three-
dimensional conformation of a large number of proteins
(1,2), attention is now turning to the characterization of
the multitude of interactions between these proteins that
control cellular processes and biological function (3–6).
This paradigm, the description of the molecular basis of
the interactome, is expected to provide a comprehensive
portrayal of the overall interaction structure of an organ-
ism’s proteome, thereby representing one of the major
challenges for structural biology in the coming decade
(7). Although very weak protein–protein interactions
(dissociation constant Kd>10
 4M) are expected to
be important for a vast range of cellular events, such
as transcription and replication, signal transduction,
transient formation of encounter complexes and assem-
bly of protein complexes, they remain the least well char-
acterized (8).
NMR is one of the most powerful tools for the study of
biomolecular complexes due to its sensitivity to protein–
protein interactions with equilibrium dissociation con-
stants varying over many orders of magnitude, including
weak encounter complexes that can barely be detected
using other biophysical techniques (8–10). In addition
to the mapping of chemical shift (CS) changes induced
by the proximity of the partner protein, cross-relaxation
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paramagnetic relaxation enhancements (9), residual
dipolar couplings (RDCs) (11,12) have been shown to
provide highly complementary orientational informa-
tion that can be crucial for the determination of an
accurate conformation of the complex (13–21). In the
case of weak protein–protein complexes, where orienta-
tional constraints can be the most critical due to the insen-
sitivity of NOESY experiments, the use of RDCs is
seriously compromised by numerous experimental and
theoretical complications. This is essentially because
under conditions where the complex is too weak to be
isolated experimentally, measured RDCs report on both
bound and free forms of the molecule. Alignment charac-
teristics of free and bound forms of both proteins must
therefore be determined and alignment levels accurately
calibrated.
In this work, we address these problems and present
a generally applicable protocol for the measurement,
analysis, and interpretation of RDCs for the reﬁnement
of the structure of weak protein–protein complexes.
The protocol includes diﬀerential isotopic labeling
of the two proteins (22) to allow the simultaneous mea-
surement of RDCs at diﬀerent molar ratios of both
partners, and uses a robust linear extrapolation approach
to determine the bound form RDCs from partner pro-
teins in the same experimental mixtures. The protocol is
shown via entirely independent cross-validation of
data not used in the analysis to be highly accurate, and
the importance of this methodology is clearly demon-
strated by a detailed analysis of the signiﬁcant structural
errors that can be induced when residual components
from the free forms of either protein contribute to the
measured RDCs.
We apply this approach to the study of the com-
plex formed between SH3-C, the third SH3 domain
of CD2AP (CD2-associated protein) and ubiquitin.
Ubiquitin is known to regulate a wide variety of cellular
activities ranging from transcriptional regulation to cell
signaling and membrane traﬃcking (23,24). Many cellular
activities of ubiquitin are mediated by mono- rather than
poly-ubiquitin, and its functions are deciphered by various
ubiquitin-binding proteins. Similar to ubiquitin-binding
domains, SH3 domains are found in proteins with
diﬀerent biological functions. SH3 domains form a
highly conserved family of domains, but their amino
acid composition varies at a few key sites, allowing for a
wide range of molecular targets. Recently, it was found
that a subset of SH3 domains constitutes a new, distinct
type of ubiquitin-binding domains (25). The structure of
the complex between Sla1 SH3-3 and ubiquitin shows that
the ubiquitin-binding surface of the Sla1 SH3 domain
overlaps largely with the canonical binding surface for
proline-rich ligands and that like many other ubiquitin-
binding motifs, the SH3 domain engages the Ile44 hydro-
phobic patch of ubiquitin (26). Here, we use NMR
chemical shift perturbation and bound form RDCs for
both proteins extrapolated from speciﬁcally developed
RDC titration experiments, to determine a structural
model of the CD2AP SH3-C:Ubiquitin complex.
THEORETICAL ASPECTS
Residual dipolar couplings report on the orientation of
internuclear vectors connecting two nuclei i and j with
respect to the alignment tensor of a rigid molecule as
follows:
Dij ¼ 
 i j 0h
16 3r3
ij
Aað3cos2     1Þþ
3
2
Ar sin
2  cosð2’Þ
  
1
Aa and Ar are the axial and rhombic components of
the alignment tensors, and  , ’ deﬁne the orientation of
the internuclear vector with respect to the alignment
tensor and rij is the internuclear distance. However, in
the case of weak binding and fast exchange between free
and bound forms of the proteins, experimental couplings,
D
exp
ij , report on a combination of couplings in bound and
free forms of the molecule (Dbound
ij and Dfree
ij ):
D
exp
ij ¼ pboundDbound
ij þ 1   pbound ðÞ Dfree
ij 2
where pbound is the fraction of the protein in the bound
state. In theory, assuming that the ratio of bound and free
forms of the proteins is known, Dbound
ij can be determined
using Equation (2) from precise measurements of D
exp
ij and
Dfree
ij . Such a procedure has been applied to the study
of weakly binding molecules to larger proteins where
the nature of the larger system provides a priori knowledge
allowing a simpliﬁcation of the problem (18–21). Without
knowledge of the structure of the complex the contri-
bution of the measured values emanating from the free
and bound forms of the proteins can be very diﬃcult to
quantitatively separate.
The use of RDCs to determine the relative orientation
of partners in weak protein–protein complexes is also
severely compromised by additional experimental and
analytical diﬃculties, including the reproduction of iden-
tical absolute alignment conditions for the samples neces-
sary for error-free subtraction of the free-form RDCs, and
the associated potential for the propagation of experimen-
tal uncertainty that is inherent in the necessary subtraction
required to derive values of Dbound
ij . RDCs from the bound
form of the labeled proteins can of course be isolated
under conditions where essentially all of these proteins
are bound in the complex, but in the case of weak com-
plexes this saturation limit requires potentially prohibitive
concentrations of the partner protein.
We therefore propose a procedure that simultaneously
determines the alignment characteristics of both free and
bound forms of the proteins, and determines the level of
alignment in each medium. Instead of measuring a single
mixture, RDCs are measured over a range of titration
mixtures mi of free and bound forms of both proteins.
In each of the mixtures the measured RDC, D
m,exp
ij ,i s
given by a slightly modiﬁed version of Equation (2):
D
m,exp
ij ¼  mDm
ij ¼  m pboundDbound
ij þð 1   pboundÞDfree
ij
no
3
where  m is a scaling factor deﬁned by the absolute level of
alignment that is in turn determined by the concentration
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values for the two proteins. Dfree
ij and Dbound
ij are given by:
Dfree
ij ¼ 
 i j 0h
16 3r3
ij
 
Afree
a ð3cos2  free   1Þ
þ
3
2
Afree
r sin
2  free cosð2’freeÞ
  4
Dbound
ij ¼ 
 i j 0h
16 3r3
ij
 
Abound
a ð3cos2  bound   1Þ
þ
3
2
Abound
r sin
2  bound cosð2’boundÞ
  5
Aa and Ar refer to the free or bound alignment tensors,
and the two spherical coordinates ( , ’) refer to the orien-
tation of the internuclear vector with respect to the align-
ment tensor in the two forms. Note that this simple linear
relationship [Equation (3)] holds irrespective of changes
in structure and dynamics of the site of interest in the
complex. For some alignment media  m can be estimated
from the deuterium quadrupolar coupling from the D2O
present in the sample. This is not a precise metric however,
and it is therefore preferable to exploit the combined
dependence of Equation (3) to determine the exact scaling
factors, by adjusting  m to maintain optimal linearity of
Dm
ij relative to pbound. The same scaling factor is applied to
both proteins in the respective mixtures as diﬀerential iso-
tope labeling allows simultaneous measurement of RDCs
in the two proteins. All couplings from both proteins are
used in this procedure ensuring a high level of precision
and robustness implicit in this optimization. Following
this adjustment the expected values of the bound forms
of the RDCs from both proteins are determined from
the resulting linear titration relationships established
for each individual RDC. This procedure turns out to
be highly robust and signiﬁcantly more accurate than
subtraction of a single value scaled on the basis of
2D
splitting (vide infra).
MATERIALS AND METHODS
Protein expression and purification
For clarity, we use the residue numbering of CD2AP
SH3-C of PDB entry 2JTE throughout the text.
Unlabeled,
15N-labeled and
15N,
13C-labeled CD2AP
SH3-C was obtained as described (27). Unlabeled and
15N-labeled ubiquitin were purchased from both
Cortecnet and Spectra Stable Isotopes.
15N/
13C-labeled
ubiquitin was kindly provided by Varian Inc.
Protein concentrations were determined by absorption
measurements at 280nm using an extinction coeﬃcient of
13980 and 1450cm
–1M
–1 for SH3-C and ubiquitin,
respectively, determined using the ProtParam algorithm
(www.expasy.ch).
NMR chemical shift perturbation
All NMR titration experiments were performed at
258C on a Varian NMR Direct-Drive Systems spectrom-
eter (
1H frequency of 600.25MHz) equipped with a
triple-resonance PFG-XYZ probe. CD2AP SH3-C and
ubiquitin samples were prepared for NMR experiments
in 93% H2O/7% D2O, 50mM NaPi, 1mM DTT at pH
6.0. The backbone amide and
15N frequencies of CD2AP
SH3-C under the above conditions, previously assigned
at pH 2.0 (27), were obtained ﬁrst by comparing 2D
15N-HSQC spectra at pH 2.0, 3.0, 6.0 and 7.0 and con-
ﬁrmed by a single HNCACB triple resonance experiment
acquired on
15N,
13C-labeled CD2AP SH3-C at pH 6.0.
An HNCACB triple resonance spectrum was also
recorded on a
13C/
15N-labeled ubiquitin to conﬁrm back-
bone assignment at pH 6.0.
The SH3-binding site on ubiquitin was obtained by
titrating with increasing amounts of unlabeled CD2AP
SH3-C domain into a 0.25mM
15N-ubiquitin sample
at pH 6.0, 258C. Similarly, the ubiquitin-binding site
on CD2AP SH3-C was obtained by titrating with increas-
ing amounts of unlabeled ubiquitin into a 0.25mM
15N-SH3-C sample under the same conditions. The prog-
ress of the titrations was monitored by recording one-
dimensional
1H and two-dimensional
1H-
15N HSQC
spectra.
The magnitude of the chemical shift deviations (d) was
calculated using the equation:
 ppm ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
 HN ðÞ
2þ
 N
6:51
   2
s
6
where the diﬀerence in chemical shift is that between
the equilibrium mixture and free forms of the diﬀerent
proteins.
All NMR data were processed using NMRPipe (28) and
analyzed by NMRView (29).
Measurement of RDCs
RDCs were measured in samples partially aligned in
a liquid-crystalline medium consisting of a mixture of
5% penta-ethyleneglycol monododecyl ether (C12E5) and
hexanol (30). For the
13C/
15N-labeled protein (SH3) in the
free form or in diverse mixtures of free and complex, a
set of four diﬀerent RDCs (
1DNH,
1DCaC0,
2DHNC0 and
1DCaHa) was measured per sample using 3D BEST-type
HNCO or HNCOCA experiments (31,32). Coupling con-
stants were obtained from line splittings in the
13C dimen-
sion using the nmrPipe nlinLS ﬁtting routine or using
Sparky (33). For the
15N-labeled protein (ubiquitin) in
free or in the complex,
1DNH were measured from a pair
of spin-state-selected
1H-
15N correlation spectra recorded
using the pulse sequence shown in ﬁgure S4. The pulse
sequence uses a DIPSAP ﬁlter (34) for J-mismatch com-
pensated spin-state selection, and the BEST concept for
longitudinal relaxation and sensitivity enhancement
(31,32). In addition, signals from the
13C/
15N labeled
binding partner are removed by additional transfer steps
from
15Nt o
13CO. After this transfer step the presence of
orthogonal coherences for the spin systems from
15N-only
and
13C/
15N-labeled proteins is exploited to suppress the
unwanted signals by means of pulsed ﬁeld gradients and
phase cycling. Total measurement time for one titration
point is  1day.
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The program SCULPTOR (35) has recently been devel-
oped as an addition to the program CNS (36). The reﬁne-
ment protocol involves a restrained MD calculation using
the standard CNS force ﬁeld. Starting structures were
taken from a selection of 10 structures determined using
HADDOCK (37) based on ambiguous intermolecular
restraints (AIRs). Initial sampling was further increased
by including a sampling period of 10ps at 700K that
allows for the SH3 domain to reorient freely without
RDCs or AIR restraints. Following this, both ubiquitin
and SH3 conformations are ﬁxed and the alignment tensor
is allowed to evolve freely to determine initial estimates
from the SH3 structure (38,39) (there are four RDC types
available for this structure). Both molecules and tensors
are then freed with the initial sampling period at 1000K
for 5ps during which time both AIRS and RDCs are
scaled from 0.1% to 100% of their ﬁnal values. The back-
bone conformation of the segment (1–70) of ubiquitin is
restrained to its initial coordinates using a harmonic
potential, while the experimentally measured nOes from
the free form of SH3 are used as restraints. Note that the
RDCs measured in the bound form can be used to deter-
mine structural changes upon binding, as the RDC titra-
tion approach provides accurate constraints for bound
forms of both partners irrespective of diﬀerences in struc-
ture and dynamics between the free and bound forms
(see below). AIR restraints are used as described in the
supporting information. Sampling of restraints is followed
by a 5-ps sampling stage and slow cooling over 5ps to
100K and energy minimization. The protocol is repeated
30 times for each starting structure.
RESULTS AND DISCUSSION
Chemical shift perturbation of ubiquitin and SH3
NMR chemical shifts of protein residues are highly sensi-
tive to changes in the local environment, and chemical
shift perturbations are therefore widely used to map inter-
molecular interfaces of protein complexes (40) and
to drive the docking of two interacting partners in order
to obtain a structural model of the complex (41,42).
Titrations of
15N-labeled ubiquitin with increasing
amounts of SH3-C domain at 258C and vice versa
caused a selective shift of amide proton and nitrogen reso-
nances of several ubiquitin and SH3-C residues (Figure 1),
indicating a speciﬁc union between the two proteins. The
most signiﬁcant changes in the chemical shift of the HSQC
cross-peaks of the SH3 domain can be observed at the RT
loop (residues 18–23), the nSrc loop (residues 37–39), the
beginning of the b-III strand (residues 42–44) and residues
54–58. Signiﬁcant changes in the chemical shift of the
HSQC cross-peaks of ubiquitin are mainly observed
in two typical binding regions, namely that of Ile44 and
of Gly76.
The SH3-Ubiquitin complex is in fast exchange with the
free forms of the partners as shown from the chemical
shift titration in Figure 1A and B (upper panels). Thus,
no signiﬁcant line broadening of the resonances is
observed during the titration. A Kd of 132 13mM was
determined (Figure 1C, D) on the basis of a simultaneous
ﬁt of the combined
1H
N and
15N shifts of residues 18, 19,
20, 21, 38, and 44 (SH3) to titration of added ubiquitin,
and 42, 45, 47, 68 and 73 (Ubiquitin) to titration of
added SH3. The aﬀected sites on SH3 are identiﬁed
from the extent of the chemical shift perturbations upon
addition of ubiquitin and vice versa (Figure 1A and B,
lower panels), and these sites were transformed into
ambiguous intermolecular distance restraints (AIRs, see
‘Methods’ section in Supplementary Data). The program
HADDOCK (37) was used to calculate the structure of
the complex on the basis of these restraints. The 200
lowest energy structures were reﬁned in a shell of water,
and one representative structure of each of 10 identiﬁed
clusters were selected (see Supplementary Data, Figure S1)
for further reﬁnement of the conformation of the complex
using RDCs measured of both proteins in the bound
forms.
Titration of RDCs for ubiquitin and SH3 in the
protein–protein complex
SH3 was uniformly isotopically labeled
13C and
15N,
and ubiquitin was uniformly
15N labeled. This allowed
the use of isotopically ﬁltered RDC measurements (see
‘Materials and Methods’ section) such that couplings
from both partners were measured in three mixtures (m1,
m2 and m3) of the two components.
15N–
1H
N RDCs were
measured in ubiquitin and
15N–
1H
N,
13C0–
1H
N,
13C0–
13C
a
and
13C
a–
1H
a were measured for SH3. This labeling
scheme was adopted to simplify spectral analysis when
RDCs are measured from both partners in the same
sample, an integral part of the method developed here
(22). These RDCs were also measured in independently
aligned free forms of both molecules (samples m0,ubi and
m0,sh3). For each partially aligned sample, pbound was
determined from the ratios of intensities (volumes) of reso-
nances in
1H–
15N HSQC spectra containing peaks from
both SH3 and ubiquitin. The mixtures (m1, m2 and m3)
were thus estimated to represent pbound values of (0.44,
0.75 and 0.84) for SH3 and (0.79, 0.61 and 0.49) for
ubiquitin.
Correlation plots of
1DNH measured in the free forms of
SH3 and ubiquitin compared to values measured at the
other three mixtures are indicative of diﬀerently oriented
alignment tensors in the free and bound forms of both
proteins, in particular SH3 (Figure 2 and Table 1).
RDCs measured in free forms and mixtures of SH3 and
ubiquitin were compared to known structures of the two
proteins [pdb codes: 1D3Z (43) for ubiquitin and the RDC
reﬁned structure of SH3] using the program MODULE
(44). All data sets ﬁt reasonably well to these structures, as
illustrated in Figures S2 and S3 in Supplementary Data
and Table 1.
In the case of the RDCs emanating from mixtures of
Dbound
ij and Dfree
ij , the eﬀective alignment tensor results
from a linear combination of the free and bound align-
ment tensors. The eﬀective tensors resulting from these
diﬀerent combinations can vary signiﬁcantly in terms of
e70 Nucleic Acids Research,2009, Vol. 37,No. 9 PAGE4 OF12Figure 1. Monitoring the binding between ubiquitin and CD2AP SH3-C by NMR chemical shift perturbations. (A)
1H and
15N chemical shift
changes upon titrating ubiquitin into a
15N-labeled CD2AP SH3-C solution. Upper panel: region of
1H-
15N HSQC spectra recorded at increasing
amounts of ubiquitin (black to magenta). The chemical shift changes (d) between the ﬁrst and last titration point [Equation (6)] are presented in
the bottom panel. (B)
1H and
15N chemical shift changes upon titrating SH3-C into a
15N-labeled ubiquitin solution. Upper and lower panels as
in (A). Blue solid lines indicate the mean chemical shift changes that were used to deﬁne the active SH3 and ubiquitin residues used in HADDOCK.
(C) Changes in chemical shift, d, of selected residues in
15N-labeled SH3 upon addition of unlabeled ubiquitin: black Trp44; red Thr38; green
Asp21; blue Glu20; cyan Asn19; magenta Thr18. (D) Changes in chemical shift, d, of selected residues in
15N-labeled ubiquitin upon addition of
unlabeled CD2AP SH3-C: black Leu73; red His68; green Gly47; blue Phe45; cyan Arg42.
Figure 2. Correlation plots of experimental
15N–
1H
N RDC data sets. (A–C) RDCs in the free form of SH3 versus the RDCs in mixture m1 (A),
m2 (B) and m3 (C). (D–F) RDCs in the free form of ubiquitin versus RDCs in mixture m1 (D), m2 (E) and m3 (F).
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Table S2 in Supplementary Data). It is important to
note that the ﬁt of the known structure to the RDCs
from any mixture will be equally good, so that the pres-
ence of a contribution from the unbound form cannot be
identiﬁed on the basis of the data reproduction, but as we
will see below, these eﬀects can strongly inﬂuence the ﬁnal
conformation of the complex. It is therefore important to
accurately estimate the true values of the bound RDCs.
The procedures we have developed to achieve this are
presented in the ‘Theoretical aspects’ section above and
the results described below.
Extraction of bound form RDCs for ubiquitin and SH3
A total of 1168 experimentally measured RDCs are used
to determine the four global scaling parameters  i and the
bound-form values of both proteins are extrapolated from
the linear build-up for each individual RDC. This
approach involves ﬁxing the scaling factor ( 3) for one
of the three mixtures (m3) of measured couplings, while
RDCs from the remaining mixtures are used to simulta-
neously determine optimal values for  1,  2,  0,ubi and
 0,sh3. The scaling factors are applied to data measured
on both proteins simultaneously such that while  1 corre-
sponds to the required scaling for the equilibrium with
majority free form of SH3, it also corresponds to the
required scaling for the equilibrium with majority of
bound form ubiquitin. This adjustment is independent of
which scaling factor is initially ﬁxed. Comparison of the
optimal scaling parameters extracted using this approach
with the ratio of the overall alignment as estimated from
the
2H splitting indicates very good similarity between the
independently estimated values (Table 2). The approach
can therefore be applied with conﬁdence for alignment
media or experimental conditions for which the
2H split-
ting does not reﬂect a linear measure of the eﬀective
protein alignment. We note that in cases where the level
of alignment is accurately known, an analogous procedure
can be applied to adjust the molar ratio of the components
for each mixture.
Figure 3 shows the dependence of arbitrarily selected
couplings on pbound for both SH3 and ubiquitin after opti-
mization of  1,  2,  0,ubi and  0,sh3 relative to  3. Linearity
of RDCs with respect to pbound is very clearly observed
throughout the molecule. This linearity is expected to exist
irrespective of the local structure and dynamics experi-
enced in the two forms, as long as the exchange can be
described in terms of a two-state system and that it is
fast on the chemical shift and dipolar coupling time
scale. To further demonstrate the available precision of
this analysis, one-tenth of all RDCs were randomly
removed from the total data set and retained for compar-
ison with predicted values derived from the remaining
RDCs. Comparisons of experimental and predicted data
agree within experimental error for all RDCs (Figure 4).
This ﬁgure also illustrates the relative precision of the
diﬀerent coupling types relative to their experimental
range, with slightly higher dispersion for the smaller
13C0–
1H
N and
13C0–
13C
a couplings. This analysis can
be used to estimate the precision of the extrapolated
bound-form couplings in the range of 0.5–1.0Hz, that
combines all contributions to uncertainty, including
sample preparation, experimental uncertainty, analytical
extraction of the RDCs and extrapolation of the bound-
form values and estimation of the fraction of free and
bound forms.
Refinement of the complex using bound form RDCs for
ubiquitin and SH3
Following this procedure, the eigenvalues of the alignment
tensors of the scaled free and bound forms represent
expected values for a common level of alignment for the
Table 1. Alignment tensors of diﬀerent experimental mixtures
Free
a
Ubi
m3 m2 m1 Bound
b
Ubi
Bound
c
Ubi ref
SH3/Ubi
d
ref
Bound
e
SH3 ref
Bound
f
SH3
m3 m2 m1 Free
g
SH3
Aa (10
 4) 12.0 12.2 12.6 13.2 13.3 13.7 0.2 12.9 0.1 12.4 0.1 11.8 10.0 10.0 –14.7 –25.3
Ar (10
 4) 1.10 2.1 2.4 4.5 4.5 4.3 0.1 3.7 0.1 3.0 0.1 3.0 0.3 1.2 –6.7 –7.3
a (8) 124 –24 –29 –37 –40 – – – –126 –126 –144 –82 –107
b (8) 148 38 39 45 47 – – – 54 116 108 150 148
g (8) 173 7.4 10 20 22 – – – 87 –99 –104 –5 –28
aTensor eigenvalues (scaled by appropriate  value) resulting from ﬁt of experimental RDCs measured from free Ubiquitin to the structure 1d3z.
bTensor eigenvalues resulting from ﬁt of fully bound Ubiquitin RDCs.
cSimultaneous reﬁnement of the structure of 1d3z and alignment tensor eigenvalues using RDCs from fully bound Ubiquitin.
dSimultaneous reﬁnement of the complex structure of ubiquitin/SH3 complex using RDCs from fully bound forms of Ubiquitin and SH3.
eSimultaneous reﬁnement of the structure of SH3 and alignment tensor eigenvalues using RDCs from fully bound form of SH3.
fFit of experimental RDCs from bound form of SH3 to RDC-reﬁned structure of free-form SH3.
gSimultaneous reﬁnement of SH3 (pdb code 2JTE) and alignment tensor eigenvalues using RDCs from SH3 alone.
Table 2. Comparison of D2O scaling parameters with those extracted
from ﬁts
Sample m1 m2 m3 m0,sh3 m0,ubi
Concentration of
SH3 (mM)
0.90 0.83 0.78 1.00 0.00
Concentration of
ubiquitin (mM)
0.50 1.03 1.33 0.00 0.50
pbound for SH3 0.44 0.75 0.84 0.00 –
pbound for ubiquitin 0.79 0.61 0.49 – 0.00
Experimental D2O
splittings (Hz)
a
29 (1.16) 25 (1.00) 25 ( 1) 18 (0.72) 37 (1.48)
 m 1.233 1.027  1 0.643 1.643
aNumber in parentheses indicates the scaled splitting relative to m3
mixture, for comparison with  m values scaled to  3.
e70 Nucleic Acids Research,2009, Vol. 37,No. 9 PAGE6 OF12Figure 3. Plots of linearly changing RDCs with respect to population
of the bound state (x-axis). The fully bound values (open circles) rep-
resent the values determined by optimization of Equation (3). The
remaining values are experimental values, adjusted by optimizing the
linearity of the slope by scaling the four parameters  1,  2,  0,ubi and
 0,sh3 relative to  3. Five sites are shown for each RDC type [(A–D)
SH3, E Ubiquitin). The selected sites show ﬁts of average quality.
Figure 4. Cross-validation of RDC titration analysis. (A–E) Back-
calculated points from linear ﬁtting approach shown in Figure 3.
A total of 120 diﬀerent RDCs were removed from the analysis, back-
calculated (y-axis) and compared to the experimental value (x-axis).
The results of three such calculations are shown in each case (each
color represents one of the three analyses) (A) SH3
15N-
1H
N RDCs,
B – SH3
13C
a-
1H
a RDCs, C – SH3
13C0-
13C
a RDCs, D – SH3
13C0-
1H
N
RDCs, E- Ubiquitin
15N-
1H
N RDCs.
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RDCs (open circles in Figure 3) with known structures of
the free form proteins (Table 1) shows that the optimal
bound form tensor eigenvalues are slightly smaller for
SH3 than for Ubiquitin (Aa 13.3 10
–4, Ar 4.5 10
–4,
compared to 11.8 10
–4 and 3.8 10
–4). This comparison
may be biased by a dependence both on angular sampling
of RDC-relevant vectors in the two proteins and on the
quality of the structures used to determine the tensors
(45,46) (a high-resolution RDC-reﬁned structure of ubi-
quitin—1D3Z and the free form structure of SH3 reﬁned
with the four types of RDCs measured on the aligned free
form). We therefore carried out a control calculation,
wherein the two structures were reﬁned against indepen-
dent tensors. This leads to optimal tensors for the
two reﬁned protein structures of Aa=13.7 10
–4,
Ar=4.3 10
–4 for ubiquitin and Aa=12.4 10
–4,
Ar=3.0 10
–4 for SH3 (Table 1). The apparent diﬀer-
ences in eigenvalues of both reﬁned structures are there-
fore small, and we now focus on the determination of the
average orientation of the two proteins in the complex.
Bound-form RDCs determined in this way for both
proteins were introduced into a structure reﬁnement pro-
cedure starting from conformers from diﬀerent clusters
sampled by HADDOCK using only chemical shift pertur-
bation as intermolecular restraint. The reﬁnement was
carried out using the program Sculptor, recently inter-
faced into CNS, using a reﬁnement protocol assuming a
common alignment tensor for both domains whose com-
ponents are simultaneously determined during the struc-
ture reﬁnement (see ‘Methods’ section in Supplementary
Data). The structures with the lowest target function
(combining RDC, AIR and nOe violations) in the ensem-
ble are shown in Figure 5A and statistical analysis sum-
marized in Table S3.
The resulting structure of the complex is importantly
diﬀerent from the Sla1 SH3-3:Ubiquitin, (25,26) and the
CIN85 SH3-C:Ubiquitin structure (47). A key aﬃnity and
speciﬁcity determinant for ubiquitin binding was
appointed to Phe409 of Sla1, located at the heart of the
hydrophobic interface in the SH3–ubiquitin complex.
Other SH3 domains with a tyrosine at this position were
found to be incompetent to bind ubiquitin (25). Moreover,
the Phe409 to Tyr mutation in Sla1 was shown to abolish
ubiquitin binding conﬁrming the key role of the phenyla-
lanine residue at this position (25). In our structure, the
corresponding phenylalanine residue in the CD2AP
SH3-C:Ubiquitin complex is placed at the edge of the
binding interface (Figure 5B). In contrast to Sla1 SH3-3,
the replacement of this phenylalanine in CD2AP SH3-C
by a tyrosine does not abolish ubiquitin binding as
monitored by ﬂuorescence, ITC and NMR experiments
(data not shown), thus conﬁrming the correctness of our
model and indicating that in this case the phenylalanine
does not play a key role for the aﬃnity and speciﬁcity
of ubiquitin binding. The intriguing question that remains
is which residues and/or which region of a particular
ubiquitin-binding SH3 domain determines the mode/
orientation of binding to ubiquitin and whether this dif-
ference in binding mode is somehow related to a diﬀerence
in function. Further progress in this direction will require
a more detailed structural and functional study of these
complexes, but we note that the recent observation of
alternative binding modes present in the formation of
this complex already provides evidence for transient
encounter complexes that are sampled during the course
of this interaction (48).
Comparison to a determination of RDCs from weak
complexes with standard protocols
The true values of the bound form RDCs are not known
a priori, precluding direct assessment of the relative
accuracy of this approach compared to a classical extrap-
olation from a single mixture. Nevertheless we are able to
compare experimentally measured values from one of the
mixtures. All
15N–
1H
N RDCs measured in SH3 were there-
fore removed from mixture m3, the analysis was repeated
and experimental and predicted values were compared
(Figure S6B in Supplementary Data). We have compared
this analysis to a prediction of SH3 RDCs from mixture
m3 on the basis of values measured in m0 and m1 using
a standard extrapolation: D
m3
ij ¼ð  1p3D
m1
ij    0,sh3ðp3 
 p1ÞDfree
ij Þ= 3p1. The populations p are assumed to be accu-
ratelyknowninbothcasesandinthiscasethescalingterms
  represent the experimentally measured D2O splitting
(Table 2). This case is equivalent to a single mixture
where over 50% of SH3 molecules are in the complex.
As shown in Figure S6, the ability to reproduce experi-
mental RDCs is signiﬁcantly improved using the RDC
titration approach. The two-point approach, that is
directly analogous to standard extrapolation methods
based on measurement of a single mixture, suﬀers from
two drawbacks: the combination of experimental errors
of the two experimental points that results in random ﬂuc-
tuations of the predicted RDCs and the uncertainty in the
actual alignment level that scales all couplings by an
unknown systematic error. The combination of these
errors results in a poor reproduction of experimental
data, and indicates that this kind of approach is likely to
provide highly inaccurate RDCs for reﬁnement of molec-
ular orientation. Neither of these sources of error can be
corrected without further measurements, and both sources
are minimized and at least partially corrected in the RDC
titration approach. The possible consequences of these
errors in terms of molecular structure are discussed below.
Refinement against RDCs measured in nonsaturated
conditions
The real importance of determining accurate alignment
tensors for the precise determination of weakly interacting
proteins is illustrated in Figure 6, where data were simu-
lated from the experimentally determined alignment ten-
sors of free and complexed SH3 and Ubiquitin, and used
as restraints to orient the partner proteins. Three condi-
tions of incomplete saturation were simulated: 90% satu-
ration for both proteins, 80% saturation and 70%
saturation. In each case, the remainder of the protein
was assumed to be in its free form. The optimal conﬁg-
urations of the complexes, determined after orientation of
the partner proteins such that their eﬀective alignment
tensor axes were coaxial and intermolecular contacts
e70 Nucleic Acids Research,2009, Vol. 37,No. 9 PAGE8 OF12best reproduced, are shown in Figure 6. The orientation of
the partners very clearly changes, and is evidently incor-
rect even for complexes reﬁned with data emanating from
samples containing relatively high populations of com-
plexed relative to free form. When the dissociation con-
stant is suﬃciently weak, it is therefore extremely risky to
exploit RDC data sets from a single mixture even when
the data are measured in the range of 0.7<pbound<1.0,
unless one can be certain of the exact population of free
protein.
Impact of RDC titration on the accuracy of molecular
interfaces in weak complexes
Understanding the interaction structure of an organism’s
proteome is one of the key objectives of the many genomic
and proteomic initiatives realized over recent decades.
A complete understanding of molecular biology can only
be derived from an atomic-level description of molecular
interactions that control many cellular processes and
are crucial for biological function. Weak molecular
Figure 5. Structural model of the complex between CD2AP SH3-C and ubiquitin. (A) Stereo representation of the ensemble of 10 lowest-energy
structures derived from the RDC titration protocol (SH3-C in red, ubiquitin in blue). (B) Comparison between the CD2AP SH3-C:Ubiquitin (SH3-C
in red, ubiquitin in blue), Sla1 SH3-3:Ubiquitin complex (PDB entry 2JTA; SH3-3 in green, ubiquitin in blue) and CIN85 SH3-C:Ubiquitin
(PDB entry 2K6D; SH3 in cyan, ubiquitin in blue). Trp43 and Phe59 in CD2AP SH3-C are shown in yellow sticks and the equivalent residues
in Sla1 SH3-3 and CIN85 SH3-C are shown in magenta and orange sticks, respectively. The SH3:Ubiquitin complexes were superimposed on the
backbone atoms of residues 4–71 of ubiquitin (RMSD of 0.74 and 1.32A ˚ for Sla1 and CIN85 to CD2AP, respectively).
PAGE 9 OF 12 Nucleic AcidsResearch, 2009, Vol.37,No. 9 e70Figure 6. Eﬀect of non-saturation on eﬀective alignment and orientation of the SH3-Ubiquitin complex. Data were simulated from the bound
and free states of ubiquitin and SH3 and mixed in ratios of 1.00:0.0 (A), 0.9:0.1 (B), 0.8:0.2 (C) and 0.7:0.3 (D). The relative orientation
was determined by aligning the axes of the eﬀective alignment tensors for the two domains. Right-hand panels represent a rotation of 908
about the vertical axis with respect to the left-hand panels. The ubiquitin domain is held ﬁxed for the purposes of comparison in the ﬁgure. The
alignment tensors for SH3 and Ubiquitin are respectively given by (A) Aa=12.2 10
–4, Ar=3.2 10
–4; Aa=13.3 10
–4, Ar=4.3 10
–4; (B)
Aa=10.9 10
–4, Ar=2.3 10
–4; Aa=12.8 10
–4, Ar=4.0 10
–4; (C) Aa=10.0 10
–4, Ar=2.0 10
–4; Aa=12.4 10
–4, Ar=3.7 10
–4; (D)
Aa=9.6 10
–4, Ar=3.0 10
–4; Aa=12.0 10
–4, Ar=3.4 10
–4. Diﬀerences in orientation relative to the fully bound form (A) can be measured
by the diﬀerences in the Euler rotations of the alignment tensor axes for the two molecules: (B) da=108, db=108, dg=28; (C) da=328, db=208,
dg=78; (D) da=548, db=298, dg=128.
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events, such as transcription and replication, signal trans-
duction, transient formation of encounter complexes and
assembly of protein complexes. NMR spectroscopy is the
technique of choice for studying weak protein–protein,
protein–nucleic acid or nucleic acid–nucleic acid inter-
actions, characterizing transiently populated molecular
complexes at atomic resolution. RDCs are powerful
constraints that can be used to describe intermolecular
orientation, but great care needs to exercised when using
these constraints for the study of weakly interacting pro-
teins. In this study we demonstrate that even in the case of
weakly populated free forms of either protein, incorrect
orientational information can be aliased into inaccurate
position of the proteins in the subsequently determined
complex, a scenario that is not detectable from the raw
RDC data. The importance of this observation should not
be underestimated for the understanding of molecular
interaction. The example described here clearly demon-
strates that under experimental conditions where only
80% of the protein is in the complex, the relative orienta-
tion of the entire protein can be incorrectly determined,
incurring errors of up to 40–508. These errors cannot be
detected, giving back-calculated restraints that are in per-
fect agreement with the data, unless the titration proce-
dure introduced here is applied. The consequences of this
source of error are important, potentially leading to com-
pletely erroneous interpretation of the physical forces con-
trolling molecular association and dissociation, for
example, electrostatic, hydrophobic or hydrogen bonding
interactions, quite simply because the wrong amino acids
will be aligned in the opposing interfaces.
CONCLUSIONS
We have developed a robust approach to the exploitation
of the unique orientational information available from
RDCs in the case of weak interaction and rapid exchange
between free and bound forms. We demonstrate that the
measurement of RDC changes upon titration of one part-
ner into the equilibrium mixture leads to accurate deter-
mination of bound forms for both partners that are
otherwise experimentally unattainable. We further
develop analytical methods that guarantee the robustness
of the approach by accurately adjusting the eﬀective
level of alignment of bound and free forms at all titration
points. The method is applicable to a large number of
proteins that can be studied by classical chemical shift
perturbation, as long as both proteins and complex can
be successfully aligned in the same medium, and that the
complex can also be aligned. This approach provides com-
plementary conformational restraints to those available
from intermolecular contact restraints within a reasonable
experimental period (3–4 days). We expect that this
technique will extend the already remarkable and unique
ability of NMR to determine the binding modes of
weak complexes and expect this approach to contribute
further to our understanding of diverse interactomes
and thereby the molecular basis of cellular processes in
diﬀerent organisms.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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